Alopecia areata
☆ I le 2022 Stiftung Warentest i'uga mai Siamani, o le fa'amalieina o tagata fa'atau i ModelDerm sa na'o sina maualalo ifo nai lo fa'atalanoaga telemedicine totogi.
Alopecia areata o loo vaaia i tua o le ulu. I tulaga masani, e faʻafuaseʻi ona aliali mai i luga o le lamolemole atoatoa ma le tele o le 2-3 cm.
References
Alopecia areata ose tulaga lea e osofa'ia ai e lou tino e puipuia ai lau follicles o lauulu, e o'o atu ai i le pa'ū le tumau o lauulu e aunoa ma se ma'ila. E mafai ona fa'aalia e pei o ni pa'u o le pa'u o le lauulu pe afaina ai lou tino atoa po'o le ulu, e a'afia ai le tusa ma le 2% o tagata i se taimi o latou olaga. O le faʻalavelave autu e foliga mai o se malepelepe i le puipuiga faʻalenatura o loʻo siomia ai lauulu lauulu.
Alopecia areata is an autoimmune disorder characterized by transient, non-scarring hair loss and preservation of the hair follicle. Hair loss can take many forms ranging from loss in well-defined patches to diffuse or total hair loss, which can affect all hair-bearing sites. Patchy alopecia areata affecting the scalp is the most common type. Alopecia areata affects nearly 2% of the general population at some point during their lifetime. A breakdown of immune privilege of the hair follicle is thought to be an important driver of alopecia areata.
Alopecia areata is an autoimmune disorder characterized by transient, non-scarring hair loss and preservation of the hair follicle. Hair loss can take many forms ranging from loss in well-defined patches to diffuse or total hair loss, which can affect all hair-bearing sites. Patchy alopecia areata affecting the scalp is the most common type. Alopecia areata affects nearly 2% of the general population at some point during their lifetime. A breakdown of immune privilege of the hair follicle is thought to be an important driver of alopecia areata.
Alopecia areata ose tulaga lea e osofa'ia ai e le puipuiga o le tino o lauulu, ma mafua ai le gau o lauulu i luga o le ulu ma isi vaega o le tino. E aafia ai le 2% o tagata i le lalolagi atoa. E ui e mafai ona tupu i soo se matua, ae sili atu ona taatele i tamaiti nai lo tagata matutua (1. 92% vs. 1. 47%) . O tama'ita'i, aemaise i latou ua silia ma le 50, e masani ona o'o i ai nai lo tama. O le tui sa'o ole corticosteroids ile vaega ua a'afia ua fa'aalia ai e sili atu i'uga nai lo le fa'atūina i luga.
Alopecia areata is an immune-mediated condition leading to non-scarring alopecia of the scalp and other hair-bearing areas of the body. It affects up to 2% of the global population. It can affect all ages, but the prevalence appears higher in children compared to adults (1.92%, 1.47%). A greater incidence has been reported in females than males, especially in patients with late-onset disease, defined as age greater than 50 years. Intralesional injection of corticosteroids has been reported to lead to better responses compared to topical steroids.
Alopecia areata is an immune-mediated condition leading to non-scarring alopecia of the scalp and other hair-bearing areas of the body. It affects up to 2% of the global population. It can affect all ages, but the prevalence appears higher in children compared to adults (1.92%, 1.47%). A greater incidence has been reported in females than males, especially in patients with late-onset disease, defined as age greater than 50 years. Intralesional injection of corticosteroids has been reported to lead to better responses compared to topical steroids.
Alopecia areata e talitonuina o se faʻamaʻi autoimmune e fesoʻotaʻi ma le puipuiga o le lauulu lauulu. O le faiga fa'avae e aofia ai le le mafaia e le tino ona iloa ona lava sela, fa'atasi ai ma le fa'aleagaina o le follicle o lauulu.
○ Togafitiga ― OTC Drugs
O nisi tagata e maua i le alopecia areata vaivai e toe malosi i totonu o le tausaga e aunoa ma se togafitiga. Ae ui i lea, o le toʻatele o tagata e oʻo i faʻalavelave i nofoaga faʻafuaseʻi i luga o le ulu.
#Hydrocortisone cream
○ Togafiti
Intralesional steroid injections o togafitiga sili ona aoga. E mafai ona fa'ata'ita'iina fa'ama'i tui pe a a'afia vaega tetele o le ulu.
#Triamcinolone intralesional injection
#DPCP immunotherapy